The results revealed that IL-21R played a cancer-promoting role by activating the IL-21R-STAT1-c-Jun/c-Fos regulatory axis, resulting in the production of immunosuppressive IgA+ B cells, and thus attenuated CTL activation in the tumorigenesis of MASH-driven HCC. The gene discussed is FOS; the disease is hepatocellular carcinoma.